Breast Cancer Prevention Trials: Large and Small Trials : Cancer prevention IIARUN, Banu; DUNN, Barbara K; FORD, Leslie G et al.Seminars in oncology. 2010, Vol 37, Num 4, pp 367-383, issn 0093-7754, 17 p.Article

Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor-Positive Breast CancerKIM, Chungyeul; GONG TANG; FUMAGALLI, Debora et al.Journal of clinical oncology. 2011, Vol 29, Num 31, pp 4160-4167, issn 0732-183X, 8 p.Article

Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)KLEIN, Eric A; THOMPSON, Ian M; KARP, Daniel D et al.JAMA, the journal of the American Medical Association. 2011, Vol 306, Num 14, pp 1549-1556, issn 0098-7484, 8 p.Article

A Nutrient Approach to Prostate Cancer Prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)DUNN, Barbara K; RICHMOND, Ellen S; MINASIAN, Lori M et al.Nutrition and cancer. 2010, Vol 62, Num 7, pp 896-918, issn 0163-5581, 23 p.Conference Paper

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes : The NSABP study of tamoxifen and raloxifene (STAR) P-2 trialVOGEL, Victor G; COSTANTINO, Joseph P; ROBIDOUX, André et al.JAMA, the journal of the American Medical Association. 2006, Vol 295, Num 23, pp 2727-2741, issn 0098-7484, 15 p.Article

The prostate cancer prevention trial: Current status. DiscussionHIGGINS, Betsy; THOMPSON, Ian M; FLESHNER, Neil et al.The Journal of urology. 2004, Vol 171, Num 2, pp S15-S18, issn 0022-5347, 2Conference Paper

Long-Term Survival of Participants in the Prostate Cancer Prevention TrialTHOMPSON, Ian M; GOODMAN, Phyllis J; TANGEN, Catherine M et al.The New England journal of medicine. 2013, Vol 369, Num 7, pp 603-610, issn 0028-4793, 8 p.Article

Estimated impact of the prostate cancer prevention trial on population mortalityUNGER, Joseph M; THOMPSON, Ian M; LEBLANC, Michael et al.Cancer. 2005, Vol 103, Num 7, pp 1375-1380, issn 0008-543X, 6 p.Article

Tamoxifen for the prevention of breast cancer : Current status of the national surgical adjuvant breast and bowel project P-1 studyFISHER, Bernard; COSTANTINO, Joseph P; RUNOWICZ, Carolyn D et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 22, pp 1652-1662, issn 0027-8874, 11 p.Article

Prevention of hormone-related cancers: Prostate CancerPARNES, Howard L; THOMPSON, Ian M; FORD, Leslie G et al.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 368-377, issn 0732-183X, 10 p.Article

Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliterTHOMPSON, Ian M; PAULER, Donna K; CROWLEY, John J et al.The New England journal of medicine. 2004, Vol 350, Num 22, pp 2239-2246, issn 0028-4793, 8 p.Article

Implementation of the Prostate Cancer Prevention Trial (PCPT)GOODMAN, Phyllis J; TANGEN, Catherine M; CROWLEY, John J et al.Controlled clinical trials. 2004, Vol 25, Num 2, pp 203-222, issn 0197-2456, 20 p.Article

Dietary fat and prostate cancer. DiscussionFLESHNER, Neil; BAGNELL, P. Scott; KLOTZ, Laurence et al.The Journal of urology. 2004, Vol 171, Num 2, pp S19-S24, issn 0022-5347, 2Conference Paper

Prevention of hormone-related cancers: Breast CancerDUNN, Barbara K; WICKERHAM, D. Lawrence; FORD, Leslie G et al.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 357-367, issn 0732-183X, 11 p.Article

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)RUNOWICZ, Carolyn D; COSTANTINO, Joseph P; WICKERHAM, D. Lawrence et al.American journal of obstetrics and gynecology. 2011, Vol 205, Num 6, pp 535-537, issn 0002-9378, 3 p.Article

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers : The Selenium and Vitamin E Cancer Prevention Trial (SELECT)LIPPMAN, Scott M; KLEIN, Eric A; KELLOGG PARSONS, J et al.JAMA, the journal of the American Medical Association. 2009, Vol 301, Num 1, pp 39-51, issn 0098-7484, 13 p.Article

Finasteride and high-grade prostate cancer in the prostate cancer prevention trialLUCIA, M. Scott; EPSTEIN, Jonathan I; KATTAN, Michael W et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 18, pp 1375-1383, issn 0027-8874, 9 p.Article

The prostate cancer prevention trial : Design, biases and interpretation of study resultsGOODMAN, Phyllis J; THOMPSON, Ian M; TANGEN, Catherine M et al.The Journal of urology. 2006, Vol 175, Num 6, pp 2234-2242, issn 0022-5347, 9 p.Article

Novel therapeutic molecular targets for prostate cancer: The mTOR signaling pathway and epidermal growth factor receptor. DiscussionTOLCHER, Anthony W; THOMPSON, Ian M; FORD, Leslie G et al.The Journal of urology. 2004, Vol 171, Num 2, pp S41-S44, issn 0022-5347, 2Conference Paper

The influence of finasteride on the development of prostate cancerTHOMPSON, Ian M; GOODMAN, Phyllis J; CARLIN, Susie M et al.The New England journal of medicine. 2003, Vol 349, Num 3, pp 215-224, issn 0028-4793, 10 p.Article